Form 8-K - Current report:
SEC Accession No. 0000912057-01-530761
Filing Date
2001-08-29
Accepted
2001-08-29 00:00:00
Documents
8
Period of Report
2001-08-29
Items
Item 2: Acquisition or disposition of assets
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a2058321z8-k.txt 8-K 7036
3 SECURITIES PURCHASE AGREEMENT a2058321zex-2_1.txt EX-2.1 55534
4 LOAN AGREEMENT a2058321zex-2_2.txt EX-2.2 44265
5 REGISTRATION RIGHTS AND STANDSTILL AGREEMENT a2058321zex-2_3.txt EX-2.3 52011
6 COLLABORATION AGREEMENT a2058321zex-2_4.txt EX-2.4 279378
7 DEVELOPMENT AND LICENSE AGREEMENT a2058321zex-2_5.txt EX-2.5 112020
8 CLINICAL SUPPLY AGREEMENT a2058321zex-2_6.txt EX-2.6 84968
9 PRESS RELEASE a2058321zex-99_1.txt EX-99.1 9087
  Complete submission text file 0000912057-01-530761.txt   646758
Mailing Address 2292 FARADAY AVE CARLSBAD CA 92008
Business Address 2292 FARADAY AVE CARLSBAD CA 92008 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 1727318
SIC: 2834 Pharmaceutical Preparations